nivolumab 100 mg injection price in pakistan is a prescription immunotherapy medication used to treat several types of cancer. Unlike traditional chemotherapy, which directly attacks rapidly dividing cells, nivolumab works by helping the body's immune system recognize and fight cancer cells more effectively.
Nivolumab belongs to a class of medicines called immune checkpoint inhibitors. Specifically, it blocks the programmed death-1 (PD-1) receptor found on immune cells. By blocking this pathway, nivolumab enables immune cells to better identify and attack cancer cells that might otherwise avoid immune detection.
Healthcare providers prescribe nivolumab for selected patients with cancers such as melanoma, non-small cell lung cancer, kidney cancer, head and neck cancer, bladder cancer, liver cancer, esophageal cancer, and several other malignancies. The decision to use nivolumab depends on the type and stage of cancer, previous treatments, laboratory findings, and the patient's overall health.
Treatment is administered by trained healthcare professionals through intravenous infusion in a hospital or specialized oncology clinic. Patients follow individualized treatment schedules based on their specific diagnosis and treatment response.
Because nivolumab activates the immune system, it may also cause immune-related side effects. These occur when the immune system attacks healthy tissues instead of only targeting cancer cells. Potentially affected organs include the lungs, liver, intestines, kidneys, thyroid gland, adrenal glands, skin, and other tissues.
Common side effects may include fatigue, decreased appetite, nausea, rash, itching, diarrhea, joint pain, and mild infusion-related reactions. More serious immune-related complications require prompt medical evaluation and treatment, often with corticosteroids or other immunosuppressive medications.
Patients should immediately report symptoms such as persistent cough, shortness of breath, severe diarrhea, yellowing of the skin or eyes, unusual fatigue, vision changes, or significant skin reactions. Early recognition allows healthcare providers to manage immune-related side effects before they become severe.
Regular blood tests and clinical evaluations help monitor treatment safety and effectiveness. Depending on individual circumstances, imaging studies may also be performed periodically to evaluate how the cancer is responding to treatment.
Maintaining open communication with the oncology care team is essential throughout treatment. Patients should discuss any new symptoms, medications, supplements, or planned vaccinations with their healthcare providers before making changes to their care.
Immunotherapy has transformed cancer treatment for many patients by offering another therapeutic option alongside surgery, radiation therapy, chemotherapy, and targeted therapies. Although responses vary between individuals, nivolumab has improved outcomes for many patients with advanced cancers when prescribed appropriately and monitored carefully by experienced oncology specialists.